The combination of human glandular Kallikrein and free prostrate- specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA

Angeliki Magklara, Andreas Scorilas, William J. Catalona, Eleftherios P. Diamandis*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint Dive into the research topics of 'The combination of human glandular Kallikrein and free prostrate- specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds